Provided by Tiger Fintech (Singapore) Pte. Ltd.

Axsome Therapeutics

105.07
+0.72000.69%
Post-market: 106.351.28+1.22%17:18 EDT
Volume:467.58K
Turnover:48.97M
Market Cap:5.19B
PE:-18.21
High:105.41
Open:103.73
Low:103.26
Close:104.35
Loading ...
Sep 05, 2019

Major Issues Report

Current report, items 8.01 and 9.01
Aug 20, 2019

Major Issues Report

Current report, items 8.01 and 9.01
Aug 08, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Aug 08, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Jul 29, 2019

Major Issues Report

Current report, items 1.01, 2.03, 3.02, 8.01, and 9.01
Jul 11, 2019

Major Issues Report

Current report, item 8.01
Jul 05, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 27, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 24, 2019

Major Issues Report

Current report, items 8.01 and 9.01
Jun 12, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 10, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 10, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 10, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 10, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 07, 2019

Major Issues Report

Current report, items 5.07, 8.01, and 9.01
May 09, 2019

Major Issues Report

Current report, items 1.01 and 9.01
May 09, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
May 09, 2019

Major Issues Report

Current report, items 2.02 and 9.01
May 06, 2019

Major Issues Report

Current report, items 8.01 and 9.01
Dec 15, 2016

Correspondence